Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123589802> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2123589802 endingPage "521" @default.
- W2123589802 startingPage "517" @default.
- W2123589802 abstract "Over a 10-year period, 1993-2002, Federal Aviation Administration identified 50 pilot fatalities involving atenolol, metoprolol, and propranolol, which is consistent with the fact that these drugs have been in the lists of the top 200 drugs prescribed in the U.S. In a few of the 50 pilot fatality cases, initial analysis suggested the presence of atenolol and metoprolol. However, there was no medical history with these cases supporting the use of both drugs. Therefore, atenolol, metoprolol, and/or propranolol, with their possible metabolite(s), were re-extracted from the selected case specimens, derivatized with pentafluoropropionic anhydride (PFPA), and analyzed by gas chromatography-mass spectrometry (GC-MS). The MS spectra of these three antihypertensives and a metoprolol metabolite are nearly identical. All of the PFPA derivatives had baseline GC separation, with the exception of a metoprolol metabolite product, which co-eluted with atenolol. There were four primary mass fragments (m/z 408, 366, 202, and 176) found with all of the PFPA-beta-blockers and with the interfering metabolite product. However, atenolol has three unique fragments (m/z 244, 172, and 132), metoprolol has two unique fragments (m/z 559 and 107), propranolol has four unique fragments (m/z 551, 183, 144, and 127), and the metoprolol metabolite product has two unique fragments (m/z 557 and 149). These distinctive fragments were further validated by using a computer program that predicts logical mass fragments and performing GC-MS of deuterated PFPA-atenolol and PFPA-propranolol and of the PFPA-alpha-hydroxy metabolite of metoprolol. By using the unique mass fragments, none of the pilot fatality cases were found to contain more than one beta-blocker. Therefore, these mass ions can be used for differentiating and simultaneously analyzing these structurally similar beta-blockers in biological samples." @default.
- W2123589802 created "2016-06-24" @default.
- W2123589802 creator A5002725616 @default.
- W2123589802 creator A5008832205 @default.
- W2123589802 creator A5015514906 @default.
- W2123589802 creator A5036526751 @default.
- W2123589802 date "2005-09-01" @default.
- W2123589802 modified "2023-09-27" @default.
- W2123589802 title "Gas Chromatographic-Mass Spectrometric Differentiation of Atenolol, Metoprolol, Propranolol, and an Interfering Metabolite Product of Metoprolol" @default.
- W2123589802 cites W1516221483 @default.
- W2123589802 cites W2068908293 @default.
- W2123589802 cites W2085245701 @default.
- W2123589802 cites W273370005 @default.
- W2123589802 cites W2895087986 @default.
- W2123589802 doi "https://doi.org/10.1093/jat/29.6.517" @default.
- W2123589802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16168172" @default.
- W2123589802 hasPublicationYear "2005" @default.
- W2123589802 type Work @default.
- W2123589802 sameAs 2123589802 @default.
- W2123589802 citedByCount "36" @default.
- W2123589802 countsByYear W21235898022012 @default.
- W2123589802 countsByYear W21235898022013 @default.
- W2123589802 countsByYear W21235898022015 @default.
- W2123589802 countsByYear W21235898022016 @default.
- W2123589802 countsByYear W21235898022017 @default.
- W2123589802 countsByYear W21235898022020 @default.
- W2123589802 countsByYear W21235898022022 @default.
- W2123589802 crossrefType "journal-article" @default.
- W2123589802 hasAuthorship W2123589802A5002725616 @default.
- W2123589802 hasAuthorship W2123589802A5008832205 @default.
- W2123589802 hasAuthorship W2123589802A5015514906 @default.
- W2123589802 hasAuthorship W2123589802A5036526751 @default.
- W2123589802 hasConcept C126322002 @default.
- W2123589802 hasConcept C185592680 @default.
- W2123589802 hasConcept C2776525901 @default.
- W2123589802 hasConcept C2777477808 @default.
- W2123589802 hasConcept C2778151854 @default.
- W2123589802 hasConcept C2781280847 @default.
- W2123589802 hasConcept C43617362 @default.
- W2123589802 hasConcept C55493867 @default.
- W2123589802 hasConcept C71924100 @default.
- W2123589802 hasConcept C84393581 @default.
- W2123589802 hasConcept C98274493 @default.
- W2123589802 hasConceptScore W2123589802C126322002 @default.
- W2123589802 hasConceptScore W2123589802C185592680 @default.
- W2123589802 hasConceptScore W2123589802C2776525901 @default.
- W2123589802 hasConceptScore W2123589802C2777477808 @default.
- W2123589802 hasConceptScore W2123589802C2778151854 @default.
- W2123589802 hasConceptScore W2123589802C2781280847 @default.
- W2123589802 hasConceptScore W2123589802C43617362 @default.
- W2123589802 hasConceptScore W2123589802C55493867 @default.
- W2123589802 hasConceptScore W2123589802C71924100 @default.
- W2123589802 hasConceptScore W2123589802C84393581 @default.
- W2123589802 hasConceptScore W2123589802C98274493 @default.
- W2123589802 hasIssue "6" @default.
- W2123589802 hasLocation W21235898021 @default.
- W2123589802 hasLocation W21235898022 @default.
- W2123589802 hasOpenAccess W2123589802 @default.
- W2123589802 hasPrimaryLocation W21235898021 @default.
- W2123589802 hasRelatedWork W1997533976 @default.
- W2123589802 hasRelatedWork W2004881900 @default.
- W2123589802 hasRelatedWork W2044770075 @default.
- W2123589802 hasRelatedWork W2047861063 @default.
- W2123589802 hasRelatedWork W2052460192 @default.
- W2123589802 hasRelatedWork W2073497794 @default.
- W2123589802 hasRelatedWork W2157493302 @default.
- W2123589802 hasRelatedWork W2170625447 @default.
- W2123589802 hasRelatedWork W2402709110 @default.
- W2123589802 hasRelatedWork W2600087546 @default.
- W2123589802 hasVolume "29" @default.
- W2123589802 isParatext "false" @default.
- W2123589802 isRetracted "false" @default.
- W2123589802 magId "2123589802" @default.
- W2123589802 workType "article" @default.